solriamfetol

CHEBI:CHEBI_747132

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
SOLRIAMFETOL HYDROCHLORIDE
rxcui
2173841
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
route
ORAL
listing_expiration_date
20241231
dosage_form
POWDER
dea_schedule
CIV
active_ingredient_strength
50 kg/50kg
marketing_start_date
20190106
pharm_class_moa
Dopamine Uptake Inhibitors [MoA]
package_marketing_start_date
08-SEP-20
labeler_name
Glenmark Life Sciences Limited
manufacturer_name
Axsome Therapeutics, Inc.
brand_name
SUNOSI
brand_name_base
SUNOSI
product_ndc
44639-002
application_number
NDA211230
spl_id
647efa1a-a18f-4dc8-8c4e-6e7988772876
active_ingredient_name
SOLRIAMFETOL HYDROCHLORIDE
package_ndc
44639-002-01
package_description
1 BAG in 1 DRUM (44639-002-01) / 105000 TABLET, FILM COATED in 1 BAG
unii
939U7C91AI
spl_set_id
362f206b-73e7-4009-8c34-5a9df55679ab
nui
N0000000102
upc
0381968350018
pharm_class_epc
Dopamine and Norepinephrine Reuptake Inhibitor [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class